Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) Equity Average (2018 - 2025)

Dna X's Equity Average history spans 8 years, with the latest figure at -$4.3 million for Q4 2025.

  • Quarterly results put Equity Average at -$4.3 million for Q4 2025, down 189.71% from a year ago — trailing twelve months through Dec 2025 was -$4.3 million (down 189.71% YoY), and the annual figure for FY2025 was -$6.8 million, down 181.92%.
  • Equity Average for Q4 2025 was -$4.3 million at Dna X, down from -$1.0 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $23.9 million in Q1 2021 to a low of -$4.3 million in Q4 2025.
  • The 5-year median for Equity Average is $15.9 million (2021), against an average of $13.2 million.
  • The sharpest move saw Equity Average skyrocketed 134.79% in 2023, then tumbled 189.71% in 2025.
  • Year by year, Equity Average stood at $15.6 million in 2021, then skyrocketed by 30.19% to $20.4 million in 2022, then grew by 11.7% to $22.7 million in 2023, then crashed by 78.78% to $4.8 million in 2024, then plummeted by 189.71% to -$4.3 million in 2025.
  • According to Business Quant data, Equity Average over the past three periods came in at -$4.3 million, -$1.0 million, and -$1.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.